Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2010 Jan 19.
Published in final edited form as: Tetrahedron Lett. 2009 May 27;50(21):2464–2466. doi: 10.1016/j.tetlet.2009.03.092

Synthesis of Boc-protected bicycloproline

Sujeewa Ranatunga , Juan R Del Valle ‡,*
PMCID: PMC2808134  NIHMSID: NIHMS166745  PMID: 20090865

Abstract

The synthesis of a highly constrained quaternary carbocyclic α-amino acid, (+)-N-Boc-bicycloproline, has been achieved starting from sodium cyclopentadienylide. Key steps include a rhodium-catalyzed nitrenoid C–H insertion to install the tert-alkylamine and a ring-closing metathesis reaction to form the pyrrolidine ring.


Structure-based peptidomimetic drug design has been aided by the development of synthetic methods toward various rigidified amino acids (Fig. 1). Cyclic residues and quaternary α-amino acids (or α,α-dialkylated amino acids) have garnered special interest due to their ability to restrict the ψ, φ, and ω torsional angles of the peptide backbone.1 While proline is the only canonical proteinogenic amino acid harboring a cyclic constraint, various other cyclic and quaternary amino acids have been found in nature, often as components of biologically active peptides with well-defined secondary structures.2 The conformational and biological properties of many of these residues have been the impetus for a number of synthetic studies.2d,3

Figure 1.

Figure 1

General structures of some constrained α-amino acids.

In connection with our interest in α-amino acids that may have a profound influence on the amide backbone (cis–trans) rotameric equilibrium, we selected bicycloproline (octahydrocyclopenta[b]pyrrole-6a-carboxylic acid, 1) as an initial target (Fig. 2). Recently, Trauner and co-workers reported a strategy toward bicycloproline starting from Meyer's lactam, providing a potential precursor to 1.4 Although the synthesis of racemic 1 and related structural motifs has been reported in the literature,5 we describe herein the first synthesis of enantiopure N-protected bicycloproline from a readily available chiral progenitor.

Figure 2.

Figure 2

Bicycloproline and related structures.

The octahydrocyclopenta[b]pyrrole core of bicycloproline comprises a substituted cyclopentane ring fused to pyrrolidine. Assuming that the heterocyclic ring could be formed at a late stage, our strategy centered on the synthesis of a cyclopentane harboring a quaternary aminated carbon. We envisioned that the tert-alkylamino group could be installed via intramolecular C–H insertion of an oxycarbonylnitrene onto an appropriately substituted tertiary carbon.6 In our search for a useful cyclopentanoid substrate, we settled on 2-benzyloxymethylcyclopent-3-enol for its pattern of substitution and its availability from cyclopentadiene in optically pure form.7

The synthesis of (2R,3S)-2-benzyloxymethylcyclopent-3-enol was carried out following the modification by Gellman and co-workers.8 We prepared 2 in multi-gram batches over three steps9 and introduced the primary carbamate with trichloroacetylisocyanate to give 3 in 85% yield (Scheme 1). We explored a number of different conditions for the ensuing C–H insertion using Rh(II) catalysts (DuBois conditions6d) as well as the Ag(I)-catalyzed conditions recently reported by He and Cui6e. In our hands, Ag(I) catalysis failed to give appreciable amounts of insertion products. In conjunction with various Rh(II) catalysts, different permutations of oxidant (PhI(OAc)2, PhI=O), base (K2CO3, 2,6-lutidine, MgO), solvent (toluene, DCM, 1,2-DCE, benzene), and temperature were investigated. Under optimized conditions, the desired product (4) was obtained in 35% yield after purification. In addition, we isolated 13% of the isomeric product 5, as well as a small amount of aziride 6. In nearly every case screened, we observed an approximately 2:1 ratio of tertiary:secondary C–H insertion products (4:5). These results are consistent with the enhanced reactivity exhibited by more substituted carbons toward N-acyloxynitrenoids.6d,10

Scheme 1.

Scheme 1

Synthesis of 4 (RSM = recovered starting material).

In an effort to parse the factors contributing to reaction regioselectivity, we synthesized a variety of other substrates (Scheme 2). Reactions carried out with saturated substrate 7 under optimized conditions resulted in lower conversion and in 32% yield of the desired product, but no appreciable insertion at the secondary C–H bond. Substrates 9 and 11 were prepared in an attempt to compel insertion at the tertiary carbon center. Reaction of 9 under optimized conditions led to exclusive insertion at the ethereal carbon to give N-acyloxyaminal 10 as the only major product. This result was unexpected in light of the well-established preference for five-membered cyclic carbamate formation in related systems and is probably due to the blocking effect of the O-TBDPS group on the β-face of the cyclopentane ring. When the reaction was carried out with the less sterically demanding O-MOM derivative 11, the six-membered N-acyloxyaminal (12) was similarly obtained as the major product along with desired spirocycle 13. The appreciable formation of products 10 and 12 in these reactions suggests that ether substituents act as strong activators of the geminal C– H bonds. Reaction of sulfamate ester 14 under similar Rh(II)-catalyzed conditions gave 60% yield of tricyclic aziridine derivative 15.

Scheme 2.

Scheme 2

Selectivity of C–H insertion in related substrates.

Although compounds 4, 8, and 13 represented useful intermediates for our synthesis, we opted to continue with cyclopentene 4 due to step economy and higher overall yields. Compound 4 was saturated by hydrogenation and the cyclic carbamate allylated with KHMDS and allyl bromide in 82% yield (Scheme 3). Alkaline hydrolysis of the carbamate gave 17 in good yield, but Boc-protection of the resulting amine met with difficulties, providing large amounts of 16 in addition to 18. Presumably, Boc-protection is followed by rapid attack of the vicinal hydroxyl group to give the cyclic precursor. Moreover, we found compound 18 to be unstable toward subsequent oxidation conditions, and also unstable upon storage at room temperature (neat), resulting in recovery of additional 16.

Scheme 3.

Scheme 3

Synthesis of aminoalcohol 17.

As an alternative to N-acyloxy protection, the secondary amine was benzylated under standard conditions and subjected to Swern oxidation to give ketone 19. Wittig methylenation then provided diene 20 in 88% yield. In consideration of the free amine group in 20, the subsequent RCM reaction required some optimization. We found that pyrroline formation occured smoothly in 78% yield using 7 mol % of Grubbs' 2nd generation catalyst (added in two portions) in toluene at 60 °C. Treatment of 21 with Perlman's catalyst and H2 resulted in saturation and concomitant debenzylation. This was followed by Boc-protection of the crude aminoalcohol to afford 22. Finally, oxidation using sodium chlorite, bleach, and catalytic TEMPO provided N-Boc-bicycloproline (23) in 75% yield. The 1H NMR spectrum of 23 is consistent with that of the expected structure but is complicated by the presence of cis and trans carbamate rotamers. Compound 23 was recrystalized out of DCM/hexane for analysis by X-ray diffraction. The crystal structure we obtained confirmed the structure and relative stereochemistry of synthetic (+)-N-Boc-bicycloproline (Scheme 4).11

Scheme 4.

Scheme 4

Synthesis and X-ray structure of (+)-N-Boc-bicycloproline (23).

In summary, we have utilized (2R,3S)-2-benzyloxymethylcyclopent-3-enol as a practical starting material for the synthesis of bicycloproline. The key steps in our synthesis are a Rh(II)-catalyzed nitrenoid insertion reaction to provide the tert-alkylamine and a Grubbs' ring-closing metathesis to form the pyrrolidine ring. We are currently investigating the regioselectivity of C–H insertions in polyfunctional substrates for the synthesis of other complex amino acids. The incorporation of bicycloproline into host structures and its effects on peptide conformation will be reported in due course.

Supplementary Material

Experimental

Acknowledgments

We thank Leticia Montoya (New Mexico State University) and the Scripps Center for Mass Spectrometry for mass analysis of all compounds, and Dr. Eileen Duesler (University of New Mexico) for X-ray studies on compound 23. This work was supported by a grant from the National Institute of General Medical Sciences (NIH 1SC2AI081526-01).

Footnotes

Supplementary data: Supplementary data (experimental procedures, complete spectral data, copies of NMR spectra for new compounds, and X-ray and for 23) associated with this article can be found, in the online version, at doi:10.1016/j.tetlet.2009.03.092.

References and notes

  • 1.(a) Venkatraman J, Shankaramma SC, Balaram P. Chem Rev. 2001;101:3131–3152. doi: 10.1021/cr000053z. [DOI] [PubMed] [Google Scholar]; (b) Toniolo C, Crisma M, Formaggio F, Peggion C. Biopolymers. 2001;60:396–419. doi: 10.1002/1097-0282(2001)60:6<396::AID-BIP10184>3.0.CO;2-7. [DOI] [PubMed] [Google Scholar]; (c) Hruby VJ. Acc Chem Res. 2001;34:389–397. doi: 10.1021/ar990063q. [DOI] [PubMed] [Google Scholar]; (d) Gibson SE, Guillo N, Tozer MJ. Tetrahedron. 1999;55:585–615. [Google Scholar]; (e) Scheraga HA. Chem Rev. 1971;71:195. doi: 10.1021/cr60270a003. [DOI] [PubMed] [Google Scholar]; (f) Casanovas J, Jimenez AI, Cativiela C, Nussinov R, Aleman C. J Org Chem. 2008;73:644–651. doi: 10.1021/jo702107s. [DOI] [PubMed] [Google Scholar]; (g) Casanovas J, Nussinov R, Aleman C. J Org Chem. 2008;73:4205–4211. doi: 10.1021/jo8005528. [DOI] [PMC free article] [PubMed] [Google Scholar]; (h) Goodman M, Shao H. Pure App Chem. 1996;68:1303–1308. [Google Scholar]; (i) Tanaka M. Chem Pharm Bull. 2007;55:349–358. doi: 10.1248/cpb.55.349. [DOI] [PubMed] [Google Scholar]; (j) Hanessian S, McNaughtonSmith G, Lombart HG, Lubell WD. Tetrahedron. 1997;53:12789–12854. [Google Scholar]; (k) Karle IL. Biopolymers. 2001;60:351–365. doi: 10.1002/1097-0282(2001)60:5<351::AID-BIP10174>3.0.CO;2-U. [DOI] [PubMed] [Google Scholar]
  • 2.(a) Whitmore L, Wallace BA. In: Handbook of Biologically Active Peptides. Kastin AJ, editor. Elsevier; Burlington: 2006. pp. 83–88. [Google Scholar]; (b) Mauger AB. J Nat Prod. 1996;59:1205–1211. doi: 10.1021/np9603479. [DOI] [PubMed] [Google Scholar]; (c) He HY, Janso JE, Yang HY, Bernan VS, Lin SL, Yu K. J Nat Prod. 2006;69:736–741. doi: 10.1021/np058133r. [DOI] [PubMed] [Google Scholar]; (d) Ohfune Y, Shinada T. Eur J Org Chem. 2005:5127–5143. doi: 10.1021/jo0477244. [DOI] [PubMed] [Google Scholar]; (e) Fietzek PP, Kuhn K. Mol Cell Biochem. 1975;8:141–157. doi: 10.1007/BF01792765. [DOI] [PubMed] [Google Scholar]
  • 3.For reviews on the synthesis of quaternary α-amino acids see: Cativiela C, Diaz-de-Villegas MD. Tetrahedron: Asymmetry. 1998;9:3517–3599.Cativiela C, Diaz-de-Villegas MD. Tetrahedron: Asymmetry. 2000;11:645–732.Cativiela C, Diaz-de-Villegas MD. Tetrahedron: Asymmetry. 2007;18:569–623.Calaza MI, Cativiela C. Eur J Org Chem. 2008:3427–3448. doi: 10.1002/ejoc.200800225.Vogt H, Brase S. Org Biomol Chem. 2007;5:406–430. doi: 10.1039/b611091f.
  • 4.Dorsey AD, Barbarow JE, Trauner D. Org Lett. 2003;5:3237–3239. doi: 10.1021/ol035111s. [DOI] [PubMed] [Google Scholar]
  • 5.(a) Turner PG, Donohoe TJ, Cousins RPC. Chem Comm. 2004:1422–1423. doi: 10.1039/b404002c. [DOI] [PubMed] [Google Scholar]; (b) Belanger G, April M, Dauphin E, Roy S. J Org Chem. 2007;72:1104–1111. doi: 10.1021/jo061556t. [DOI] [PubMed] [Google Scholar]; (c) Ohfune Y, Demura T, Iwama S, Matsuda H, Namba K, Shimamoto K, Shinada T. Tetrahedron Lett. 2003;44:5431–5434. [Google Scholar]; (d) Overman LE, Tellew JE. J Org Chem. 1996;61:8338–8340. doi: 10.1021/jo961341r. [DOI] [PubMed] [Google Scholar]
  • 6.For leading references on insertion reactions of N-acyloxy nitrenes see: Lwowski W. In: Nitrenes. Lwowski W, editor. Interscience; New York: 1970. pp. 1–11.Meth-Cohn O. Acc Chem Res. 1987;20:18–27.Davies HML, Long MS. Angew Chem, Int Ed. 2005;44:3518–3520. doi: 10.1002/anie.200500554.Espino CG, Du Bois J. Angew Chem, Int Ed. 2001;40:598–600.Cui Y, He C. Angew Chem, Int Ed. 2004;43:4210–4212. doi: 10.1002/anie.200454243.
  • 7.Biggadike K, Borthwick AD, Evans D, Exall AM, Kirk BE, Roberts SM, Stephenson L, Youds P. J Chem Soc, Perkin Trans. 1988;1:549–554. [Google Scholar]
  • 8.Woll MG, Fisk JD, LePlae PR, Gellman SH. J Am Chem Soc. 2002;124:12447–12452. doi: 10.1021/ja0258778. [DOI] [PubMed] [Google Scholar]
  • 9.We used (–)Ipc2BH to prepare the (2S,3R) isomer of 2 as described in Ref. 8. The enantiomeric purity of 2 (>95:5) was assessed by conversion to the Mosher ester and analysis by NMR.
  • 10.Li Z, Capretto DA, Rahaman R, He C. Angew Chem, Int Ed. 2007;46:5184. doi: 10.1002/anie.200700760. [DOI] [PubMed] [Google Scholar]
  • 11.See Supplementary data.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Experimental

RESOURCES